Deep dives into and analysis of issues that impact access to medicines.
Our views on what governments and the international community can do to fight this pandemic and prepare for the next one.
Timely and topical analysis on the day-to-day issues in intellectual property and health.
Instances when authorities have invoked, planned to/were asked to invoke a flexibility contained in the TRIPS Agreement for public health reasons.
Tools to help governments and others looking to increase access to medicines by using flexibilities in intellectual property law.
Learn about Medicines Law & Policy's team of legal and policy experts.
Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms.
We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.
The latest thoughts from Medicines Law & Policy partners.
